Health TrialsbyHealthPanel

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

SNC116 Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

This study aims to evaluate the safety and pharmacokinetic profile of SNC116 in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Participants needed: 28
Trial details
Phase: Early Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Simnova Biotechnology Co.,Ltd.Updated: Sep 21, 2026Locations: 1
Eligibility criteria

Age ≥ 18 years and ≤ 75 years, with no gender restrictions. [+24]

Diagnosed with Burkitt leukemia/lymphoma or chronic myeloid leukemia with acute... [+43]

Read more
Status: Not yet recruiting

F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus

This is a phase I clinical study to evaluate the safety , pharmacokinetic profile, and preliminary efficacy of F01 in patients with moderate-to-severe refractory systemic lupus erythematosus.

Participants needed: 50
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Shanghai Simnova Biotechnology Co.,Ltd.Updated: Jun 21, 2024Locations: 1
Eligibility criteria

Age ≥18 and ≤65 years old, gender unlimited. [+14]

Known allergies, hypersensitivity, intolerance, or contraindications to F01 or a... [+23]

Read more